Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

509.70 +6.45 (+1.28%)
Delayed Quote Updated: 11:56 AM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
77 78 Next >
News headline image
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion' ↗
Goldman Sachs raises S&P 500's EPS forecast to $268 in 2025, driven by AI tech demand & semiconductor recovery. Margin expansion & macro growth fuel optimism for tech & healthcare sectors. 
Via Benzinga
Topics Artificial Intelligence Stocks
News headline image
Insider Trades: How To Find The Top Stocks ↗
There are dozens of insider trades going on every week. Here are 5 insider stock buys that stand out. 
Via Talk Markets
News headline image
3 Top Stocks That Could Still Rocket Higher in 2024 ↗
Upcoming Food and Drug Administration decisions could push these stocks through the roof. 
Via The Motley Fool
News headline image
2 Superior Growth Stocks That Are Screaming Buys Right Now ↗
These companies have plenty of growth runway left. 
Via The Motley Fool
News headline image
What Analysts Are Saying About Vertex Pharmaceuticals Stock ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today ↗
 
Via Benzinga
News headline image
Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews ↗
 
Via Benzinga
News headline image
Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. ↗
Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. 
Via Investor's Business Daily
News headline image
Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
The Best Biotech Stock to Invest $1,000 in Right Now ↗
Vertex Pharmaceuticals isn't an ordinary biotech stock. 
Via The Motley Fool
News headline image
Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗
Great companies have persisted even in a tumultuous market. 
Via The Motley Fool
News headline image
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
Looking Into Vertex Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗
These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond. 
Via The Motley Fool
News headline image
3 Stocks to Buy and Hold Forever ↗
These stocks are built for the long run. 
Via The Motley Fool
News headline image
Prediction: These 3 Phenomenal Stocks Are Set to Soar ↗
These stocks are already solid winners in 2024. They should be able to keep the momentum going. 
Via The Motley Fool
News headline image
Time To Invest And Or Trade In Bio-Tech Stocks? ↗
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs
News headline image
Biotech Breakout: Stocks for Your Watchlist
The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150. 
Via MarketBeat
Topics ETFs
News headline image
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
3 No-Brainer Stocks to Buy in September ↗
There's at least one key common denominator here: tremendous growth prospects. 
Via The Motley Fool
News headline image
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever ↗
These three have secure core businesses, plus multiple paths to grow. 
Via The Motley Fool
News headline image
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗
Vertex should have a future full of bright tomorrows. 
Via The Motley Fool
News headline image
Biotech And Life Science Sector Update Summer Of 2024 ↗
It’s the slowest week of the year, we are at the market top and most earnings reports are good. 
Via Talk Markets
News headline image
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics ↗
Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC. 
Via Benzinga
News headline image
Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead ↗
Vertex Pharmaceuticals has a lot going for it. 
Via The Motley Fool
News headline image
Vertex to Participate in Upcoming September Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Biotech Bull Market: 3 Ways To Play It ↗
Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally. 
Via Talk Markets
Topics Economy
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
77 78 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.